4-甲氧基甲基苯胺 | 80936-82-9

• 物质功能分类: 有机原料 - 氨基化合物 - 环烷胺、芳香单胺、芳香多胺及其衍生物和盐
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲氧基甲基苯胺
• 英文名称: 4-(methoxymethyl)aniline
• CAS: 80936-82-9
• 化学式: C₈H₁₁NO
• mdl: MFCD06804487
• 分子量: 137.181
• InChiKey: URSADVDNUKPSIK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xn
• 危险类别码：
  R22
• 海关编码：
  2922199090
• 危险性防范说明：
  P273
• 危险性描述：
  H302,H412
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(Methoxymethyl)aniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H412: Harmful to aquatic life with long lasting effects
P273: Avoid release to the environment

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(Methoxymethyl)aniline
CAS number: 80936-82-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H11NO
Molecular weight: 137.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-甲氧基甲基苯胺 在 盐酸 、 氯化铵 、 溶剂黄146 、 锌 作用下， 以 水 、 丙酮 为溶剂， 反应 0.75h， 生成 联苯胺
  参考文献：
  名称：

  4-烷基取代的azo苯的4.4'-联苯胺重排

  摘要：

  当用稀无机酸处理过的Ñ，Ñ在4-位具有烷基取代基“-diarylhydrazines（hydrazobenzenes）经历[5,5] -sigmatropic重排反应，得到4-（4'-氨基苯基）-4- alkylcyclohexa -2- ，5- dienimines（本位-benzidines）在中度至良好的产率。在起始原料的4-烷基取代基的空间位阻减小了各自的产率本位-联苯胺。邻位和/或间位的其他供电子烷基取代基两个环上的-位通常促进反应并因此增加4.4'-联苯胺重排产物的产率。在此描述的是我们关于这种异常的联苯胺重排的范围和限制的发现。

  DOI：

  10.1016/j.tet.2016.03.103
• 作为产物：
  描述：

  4-溴苄醇 在 ammonium hydroxide 、 copper(l) iodide 、 sodium hydride 、 caesium carbonate 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 、 乙酰丙酮 为溶剂， 反应 9.0h， 生成 4-甲氧基甲基苯胺
  参考文献：
  名称：

  [EN] OXAZOLIDINONE HYDROXAMIC ACID COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
  [FR] COMPOSÉS D'ACIDE OXAZOLIDINONE-HYDROXAMIQUE POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES

  摘要：

  这项发明通常涉及使用式I的有机化合物治疗细菌感染。在某些方面，该发明涉及治疗由革兰氏阴性细菌引起的感染。其中X、Y、R1、R2、R3、R4和R5在此定义。

  公开号：

  WO2015066413A1

文献信息

• Fluorescent Perylene Diimide Rotaxanes: Spectroscopic Signatures of Wheel–Chromophore Interactions
  作者：Jacob Baggerman、Dhiredj C. Jagesar、Renaud A. L. Vallée、Johan Hofkens、Frans C. De Schryver、Frauke Schelhase、Fritz Vögtle、Albert M. Brouwer

  DOI：10.1002/chem.200601014

  日期：2007.1.22

  [2]- and [3]-rotaxanes with a tetraphenoxy perylene diimide core were synthesized. Hydrogen bonding between the wheel and the imide changes the optical properties of the perylene chromophore: the absorption and fluorescence spectra are red-shifted. The decay times of the rotaxanes are shorter in comparison with that of the axle. Single molecule fluorescence measurements reveal relatively narrow distributions

  合成具有四苯氧基per二酰亚胺核的[2]-和[3]-轮烷。砂轮和酰亚胺之间的氢键改变了pe​​r生色团的光学性质：吸收光谱和荧光光谱发生红移。与轮轴相比，轮烷的衰减时间更短。单分子荧光测量揭示了最大发射和衰减时间的相对窄的分布。平均值与整体测量值一致。观察到的红移使the二酰亚胺成为一种合适的生色团，用于检测车轮在车轴上的位置。
• Indium as a Reducing Agent: Reduction of Aromatic Nitro Groups
  作者：Christopher J. Moody、Michael R. Pitts

  DOI：10.1055/s-1998-1837

  日期：1998.9

  Treatment of a range of aromatic nitro compounds with indium powder in aqueous ethanolic ammonium chloride results in selective reduction of the nitro groups; ester, nitrile, amide and halide substituents are unaffected.

  在含有水-乙醇的氯化铵溶液中，利用铟粉处理一系列芳香族硝基化合物，可以选择性地还原硝基官能团；酯基、氰基、酰胺基和卤素取代基并不会受到影响。
• Indium metal as a reducing agent in organic synthesis
  作者：Michael R. Pitts、Justin R. Harrison、Christopher J. Moody

  DOI：10.1039/b101712h

  日期：——

  aromatic nitro compounds under similar conditions results in selective reduction of the nitro groups; ester, nitrile, amide and halide substituents are unaffected. Likewise indium in aqueous ethanolic ammonium chloride is an effective method for the deprotection of 4-nitrobenzyl ethers and esters. Indium is also an effective reducing agent under non-aqueous conditions and α-oximino carbonyl compounds can

  铟的低第一电离能（5.8 eV）及其对空气和水的稳定性表明，这种金属元素应是有机基材的有用还原剂。使用铟金属还原C描述了肟，硝基化合物和共轭烯烃的亚胺中的N键，苯并稠合的氮杂环中的杂环以及4-硝基苄基保护基的去除。因此，使用乙醇氯化铵水溶液中的铟金属选择性地还原喹啉，异喹啉和喹喔啉中的杂环。在相似条件下处理一系列芳香族硝基化合物会导致硝基的选择性还原；酯，腈，酰胺和卤化物取代基不受影响。同样地，乙醇乙醇铵水溶液中的铟是使4-硝基苄基醚和酯脱保护的有效方法。铟在非水条件下也是有效的还原剂，α-肟基羰基化合物可以选择性地还原为相应的N-在乙酸酐或二碳酸二叔丁酯存在下，用铟粉，乙酸在THF中的叔胺保护。在THF-乙酸中的铟也会还原共轭烯烃。
• [EN] (AZA)INDOLE-, BENZOTHIOPHENE-, AND BENZOFURAN-3-SULFONAMIDES<br/>[FR] (AZA)INDOLE, BENZOTHIOPHÈNE ET BENZOFURAN-3-SULFONAMIDES
  申请人：UCB PHARMA GMBH

  公开号：WO2018122232A1

  公开（公告）日：2018-07-05

  Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.

  揭示了具有GPR17调节特性的磺胺类化合物，可用于治疗或预防各种中枢神经系统和其他疾病，特别是用于预防和治疗髓鞘疾病或紊乱。
• Aryl triazines as LPAAT-SS inhibitors and uses thereof
  申请人：Cell Therapeutics, Inc.

  公开号：US20030153570A1

  公开（公告）日：2003-08-14

  The invention relates to aryl triazines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase &bgr; (LPAAT-&bgr;) activity and/or proliferation of cells such as tumor cells.

  本发明涉及芳基三嗪及其用途，包括用于抑制溶血磷脂酸酰基转移酶β（LPAAT-β）活性和/或诸如肿瘤细胞的细胞增殖。